Pakistan-US Science and Technology Cooperation Program |
Phase 7 (2017 Deadline)
Molecular characterization and drug design targeting emerging pathogenic bacteria of Pakistan and development of an access application for the health care industry
US Partner: Alexander MacKerell, University of Maryland
Pakistan Partner: Syed Sikander Azam, Quaid-i-Azam University
This project will develop novel, effective antibacterial therapies that can be readily translated for clinical use. It will develop web-enabled technology to allow for rapid collection and real-time analysis of novel resistant pathogens identified in hospital settings.